Paul Horton and Gina Maravilla check out some of the offerings at the 2026 Arizona Cardinals NFL Draft Party. It kicks off Thursday at State Farm Stadium. Along Route 66, tribes are reclaiming their ...

The Texas Longhorns are no strangers to making or rewriting history, as the Longhorns softball program rewrites another chapter of its history on Friday night. The Longhorns headed into a two-game ...

The U.S. on Thursday sanctioned six individuals and two companies accused of aiding North Korea in running a global scheme using remote IT workers to defraud businesses and funnel hundreds of millions ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

CHICAGO (WLS) -- Cook County it will continue funding the medical debt forgiveness program next year, once funds run out, Board of Commissioners President Tony Preckwinkle announced Tuesday. The ...

Apache Geode has been revived after a near shutdown. The project’s contributor base thinned, development stalled, and the PMC voted to terminate the project in 2024 before work resumed and culminated ...

NASA Administrator Jared Isaacman announced sweeping changes to the Artemis program on Friday morning, including an increased cadence of missions and cancellation of an expensive rocket stage. The ...

The 75,000-plus families that have signed up for New York City’s free 3-K and pre-K programs are still thousands short of last year’s final count with only two days to go until the deadline, the Daily ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.